Company: INV
Filing Date: 2025-10-23
Form Type: S-1
Source: 0001140361-25-039085
Chunk: 167

Company: Innventure, Inc.
Filing Date: 2025-10-23
Form: S-1
Chunk 167
---
 Common                                                                                                           
 Stock that may be issued upon exercise of the Series A Warrants. Mr. Joel Mermelstein is the ultimate controlling person of the listed Selling Stockholder and, accordingly, may be deemed to have voting and investment power over the 
 shares. The business address of the listed Selling Stockholder is 6500 N. Hamlin Ave., Lincolnwood, Illinois 60712.                                                                                                                     |

97

TABLE OF CONTENTS SHARES ELIGIBLE FOR FUTURE SALE The Company has 250,000,000 shares of Common Stock authorized and, as of October 14, 2025, 58,046,433 shares of Common Stock are issued and outstanding. The Company also has 25,000,000 shares of preferred stock authorized. Of the 25,000,000 shares of preferred stock authorized, 3,000,000 shares have been designated as “Series B Preferred Stock,” and 5,000,000 shares are designated as “Series C Preferred Stock.” As of October 14, 2025, (i) 33,144 shares of Series B Preferred Stock are issued and outstanding, and (ii) 150,000 shares of Series C Preferred Stock are issued and outstanding. All of the shares of Common Stock issued in connection with the Business Combination are freely transferable under the Securities Act by persons other than by the Company’s “affiliates” or Learn CW’s “affiliates” without restriction or further registration under the Securities Act. Sales of substantial amounts of Common Stock in the public market could adversely affect prevailing market prices of the Common Stock. Prior to the Business Combination, there was no public market for the Common Stock. Registration Rights In connection with the Existing Purchase Agreement entered into with Yorkville, on the Existing Debentures First Closing Date, the Company entered into a registration rights agreement (the “April SPA RRA”) with Yorkville pursuant to which Yorkville is entitled to certain registration rights under the Securities Act. Pursuant to the April SPA RRA, the Company was required to, on or before the 15th calendar day following the date the Company filed its Annual Report on Form 10-K for the year ended December 31, 2024, file with the SEC (at its sole cost and expense) a registration statement registering the resale by Yorkville of all Existing Conversion Shares (as defined herein). The Company agreed to use its best reasonable efforts to ensure that such registration statement is declared effective by the earlier of the date that is 60 calendar